Filing Flows › Incyte (INCY) › Q2 2026 › vs Q1 2026
Incyte (INCY) Q2 2026 vs Q1 2026 (quarter over quarter)
Incyte's revenue rose $401M (+32%) from $1.3B in Q1 2026 to $1.7B in Q2 2026. Operating margin 41.7% against 23.7% (+18.0 pts).
Incyte, Q2 2026: revenue $1.7B (+38% year over year), operating margin 41.7%, net earnings $586M, operating cash flow $508M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 41.7% | 23.7% | +18.0 pts |
| Net margin | 35.0% | 23.8% | +11.1 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.7B | $1.3B | $401M | +32% |
| Other income, net | $53.6M | $42.5M | $11.1M | +26% |
| Operating profit | $698M | $301M | $397M | +132% |
| Costs & expenses | $976M | $972M | $4.6M | +0.5% |
| Pre-tax earnings | $752M | $344M | $408M | +119% |
| Cost of revenue | $105M | $105M | $434K | +0.4% |
| Research & development | $517M | $516M | $1.0M | +0.2% |
| SG&A | $352M | $328M | $23.6M | +7% |
| Net earnings | $586M | $303M | $282M | +93% |
| Income tax | $166M | $40.3M | $126M | +312% |
| Depreciation & amortization | $26.5M | $23.8M | $2.7M | +11% |
| Share-based compensation | $67.3M | $64.1M | $3.1M | +5% |
| Working capital & other | $172M | $21.9M | $150M | +684% |
| Operating cash flow | $508M | $369M | $138M | +37% |
Questions
How much did Incyte's revenue grow quarter over quarter in Q2 2026?
Incyte's revenue rose $401M (+32%) from $1.3B in Q1 2026 to $1.7B in Q2 2026. Operating margin 41.7% against 23.7% (+18.0 pts).